Data centricity is the norm and with industry facing a tsunami of data, the need to harness, manage and comply are all key priorities.
In the lead up to the 16th Annual Pharmaceutical IT Congress on the 20-21 September 2018 in London, UK; we discuss the importance of collaboration in RWE and the outlook for clinical trials data and informatics with four of the esteemed speakers.
CLINICAL TRIAL DATA & INFORMATICS
With technology permeating the market, there has been many advances in the clinical trials and informatics spaces. Marisa Cunha, Senior Biomedical Informatics Scientist at AstraZeneca and Abhindan Raghwan, Principal Scientist at Novartis share their thoughts on where the market is heading and where their key priorities lie.
Read more here: https://bit.ly/2u8kixo
MANAGEMENT OF REAL-WORLD EVIDENCE & REAL-WORLD DATA
Real-World Evidence and Real-World Data are poised to revolutionise clinical development and as more and more is realised within this space, we asked Pesh Doubleday, Head of Data Resources at Public Health England and Nigel Hughes, Scientific Director at Janssen Pharma R&D for their views on this growing field.
Read more here: https://bit.ly/2MXeEoH
PHARMATEC EVENT SERIES: 3 EVENTS IN 1
Maximise the value of your data and harness the true value of digital in R&D at Oxford Global’s 16th Annual Pharma IT Congress & fast-emerging Digital Health & Digital Technologies Congress. These are part of the Pharmatec Series of events, including our 2nd Annual Artificial Intelligence in Drug Development Congress.
Bringing together over 300 senior level attendees and a panel of world-class speakers, these congresses will give you actionable insights into the latest in Big Data, R&D Informatics, Real-World Data and digital health implementation strategies.
Click here for further information: https://bit.ly/2L0fKTm
